{"id":"W4402986892","doi":"10.1200/op.2024.20.10_suppl.399","title":"US real-world utilization and outcomes of darolutamide, enzalutamide, and apalutamide for nonmetastatic castration-resistant prostate cancer (nmCRPC): DEAR-EXT study.","year":2024,"lang":"en","type":"article","venue":"JCO Oncology Practice","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Bayer (Canada)","funders":"","keywords":"Enzalutamide; Prostate cancer; Medicine; Oncology; Internal medicine; Cancer; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002075177,0.0003812163,0.00038975,0.0009067856,0.000386119,0.0008647743,0.000691946,0.0005768066,0.001958979],"category_scores_gemma":[0.003389071,0.0003212236,0.001124761,0.001909603,0.0002235044,0.0008017906,0.0008271632,0.0007826605,0.0006228318],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009344892,"about_ca_system_score_gemma":0.000901406,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007204847,"about_ca_topic_score_gemma":0.009057451,"domain_scores_codex":[0.9985885,0.0004616091,0.0002229039,0.0003144216,0.0002711159,0.0001415656],"domain_scores_gemma":[0.9939075,0.000602881,0.004029682,0.0003436,0.0005893699,0.0005269973],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005840293,0.0006023825,0.9857556,0.0001620652,0.0009163827,0.00007114567,0.0001285386,0.0002073689,0.0002038071,0.00007139668,0.002335182,0.003705849],"study_design_scores_gemma":[0.0009036384,0.002213198,0.9924935,0.00005859012,0.0005428142,0.0003513613,0.0002780343,0.0006152194,0.0002117472,0.00005338956,0.002249436,0.00002909472],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9752957,0.0004843094,0.0002209061,0.0001053103,0.00001276917,0.0002669965,0.02241116,0.00001588302,0.001186897],"genre_scores_gemma":[0.9770423,0.0002324687,0.0004275749,0.0002190917,0.00003459807,0.0003961661,0.02109795,0.00001331058,0.0005365234],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007204847,"threshold_uncertainty_score":0.01432586,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07738946556382287,"score_gpt":0.4619376274253936,"score_spread":0.3845481618615708,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}